We @MSF_access have listed in a background document some of the access challenges and supply constraints for #tocilizumab, #lopinavir-ritonavir, #remdesivir, #favipiravir. The document will be regularly updated and include other candidates for #COVID19 msfaccess.org/access-challen…
00:06 - 29 May 2020